A first-in-class multimodal organomercury compound demonstrates preferential blast reduction with improved hematopoietic and immune health in ALL
- Open access
The AI brief for this paper is being written. Open it in JClub to read the paper with the brief as soon as it lands.
Read the brief in JClub →